Managing Mild to Moderate Pediatric Atopic Dermatitis: Pathogenesis and Therapies for Improved Outcomes - A CE-Certified, Online Challenge
A fast, fun and effective way to improve the way you treat and manage pediatric atopic dermatitis. You choose how, where and when to participate via web or on your mobile device.
ARE YOU UP FOR THE CHALLENGE? ENROLL TODAY! https://www.surveymonkey.com/r/PediatricAD
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and will be awarded 1.5 NAPNAP contact hours, of which 0.75 is pharmacology content.
IMPORTANT: This continuing education activity is FREE to all participants.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: firstname.lastname@example.org
Pediatric-focused advanced practice registered nurses (APRNs)
Summarize the role of skin barrier dysfunction and inflammatory responses in atopic dermatitis pathogenesis
Recognize the symptoms of atopic dermatitis and how they differ in presentation in infants, children, and adolescents
Evaluate the benefits and limitations of current therapies for mild to moderate atopic dermatitis
Assess the efficacy and safety of emerging therapies and their potential role in treating atopic dermatitis
According to the disclosure policy of NAPNAP, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosures are as follows:
Judith A. J. O’Haver, PhD, RN, CPNP-PC
Pediatric Nurse Practitioner
Department of Dermatology
Phoenix Children’s Hospital
Judith A. J. O’Haver, PhD, RN, CPNP-PC - Research Support - Sub-investigator (institution): Anacor Pharmaceuticals, Inc
National Association of Pediatric Nurse Practitioners
Heather Keesing, MSN, RN, APRN; Laura Nelsen; Daniela Weitzman: No relevant financial relationships with any commercial interests.
Aisha Cobbs, PhD and Christine Kocienda: No relevant financial relationships with any commercial interests.
NAPNAP CE Chair
Lori Williams, DNP, RN, RNC-NIC, CCRN, NNP-BC: No relevant financial relationships with any commercial interests.
- 1.50 Contact hours